Market Cap 2.86B
Revenue (ttm) 0.00
Net Income (ttm) -209.13M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,500,100
Avg Vol N/A
Day's Range N/A - N/A
Shares Out 105.05M
Stochastic %K 8%
Beta N/A
Analysts Strong Sell
Price Target $47.00

Latest News on MTSR

This weight-loss drug stock could deliver a 90% return in 2025

Feb 25, 2025, 8:47 AM EST - 5 weeks ago

This weight-loss drug stock could deliver a 90% return in 2025


Weight-loss drug developer Metsera raises $275 million in US IPO

Jan 30, 2025, 7:05 PM EST - 2 months ago

Weight-loss drug developer Metsera raises $275 million in US IPO


Metsera Announces Pricing of Initial Public Offering

Jan 30, 2025, 6:53 PM EST - 2 months ago

Metsera Announces Pricing of Initial Public Offering


Metsera Readies $275 Million IPO For Obesity Treatments

Jan 28, 2025, 4:48 PM EST - 2 months ago

Metsera Readies $275 Million IPO For Obesity Treatments


Metsera IPO Registration Document (S-1)

Jan 10, 2025, 4:46 PM EST - 2 months ago

Metsera IPO Registration Document (S-1)